Sort
10,766 grants matching “checkpoint inhibitor”
Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy
$390,077Benjamin Alan Youngblood · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Investigating the Cell Division Machinery
$390,000Jorge Torres · University Of California Los Angeles · R35 · FY2023 · GM
The role of ATRX mutation in the epigenetic dysregulation of cell cycle in pediatric high-grade glioma
$390,000Carl J Koschmann · University Of Michigan At Ann Arbor · R01 · FY2025 · NS
Investigating the Cell Division Machinery
$390,000Jorge Torres · University Of California Los Angeles · R35 · FY2022 · GM
The role of ATRX mutation in the epigenetic dysregulation of cell cycle in pediatric high-grade glioma
$390,000Carl J Koschmann · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Investigating the Cell Division Machinery
$390,000Jorge Torres · University Of California Los Angeles · R35 · FY2024 · GM
The role of ATRX mutation in the epigenetic dysregulation of cell cycle in pediatric high-grade glioma
$390,000Carl J Koschmann · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Leveraging single-cell co-culture and gene expression profiling to identify tumor antigen-specific T cells in oral cancer
$390,000Joseph Zenga · Medical College Of Wisconsin · R01 · FY2025 · DE
The role of ATRX mutation in the epigenetic dysregulation of cell cycle in pediatric high-grade glioma
$390,000Carl J Koschmann · University Of Michigan At Ann Arbor · R01 · FY2023 · NS
Investigating the Cell Division Machinery
$390,000Jorge Torres · University Of California Los Angeles · R35 · FY2021 · GM
Investigating the Cell Division Machinery
$390,000Jorge Torres · University Of California Los Angeles · R35 · FY2025 · GM
Novel mechanism of chemokine nitration in bladder cancer
$389,848Neelam Mukherjee · University Of Texas Hlth Science Center · R01 · FY2024 · CA
Chemical Genetic and Biochemical Studies of Mitotic Proteolysis
$389,776Randall W King · Harvard Medical School · R01 · FY2014 · GM
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
$389,775Paul E Kinahan · University Of Washington · U24 · FY2023 · CA
Project 5: Enhancement of the Anti-Tumor Activity and Targeted Applications of Third Party Donor-Derived EBV-specific T-cells
$389,736Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$389,613Trudy Gale Oliver · University Of Utah · R01 · FY2021 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$389,613Trudy Gale Oliver · University Of Utah · R01 · FY2020 · CA
Targeting the vasculature to enhance anti-tumor immunity
$389,460Andrew Carl Dudley · University Of Virginia · R01 · FY2023 · CA
The Inhibition of HNSCC Growth and Metastasis by Targeting KDM4A
$389,423Cun-Yu Wang · University Of California Los Angeles · R01 · FY2024 · DE
Immune Activating CAR-Modified Antigen Presenting Cells
$389,375Carl Deselm · Washington University · DP5 · FY2018 · OD
Exploiting WEE1/p53 synthetic lethality as a novel therapy in head and neck cancer
$389,319Bruce E Clurman · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Kinetochore Structure and Function
$389,238Institute For Cancer Research · R01 · FY2002 · GM
Role of Ly6K in TGF-beta and immune escape pathways of triple negative breast cancer
$389,208Geeta Upadhyay · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2019 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$389,189Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2023 · CA
Linking Epigenetic-Therapy Induction of Inflammasome Signaling to Generation of a BRCAness Phenotype
$389,189Kenneth P Nephew · Coriell Institute For Medical Research · P50 · FY2022 · CA